Abstract:This article highlights the potential of azole derivatives in cancer therapy, focusing on their ability to target cancer cells and disrupt key biological pathways. It discusses recent advances, structural modifications, and ongoing research aimed at enhancing their anticancer efficacy. The review accentuates the therapeutic promise of azoles in developing innovative treatments for cancer. Monocyclic 5‐membered heterocycles including imidazoles, thiazoles, oxazoles, and their related compounds have gained significant attention in medicinal chemistry because of their potent anticancerous activity. These small heterocyclic molecules possess versatile properties, including biological activity, absorption, distribution, metabolism, excretion, and chemical diversity that give them immense potential as anticancer agents. It is also a fact that inherent characteristic of azoles to combine with many biological molecules through hydrogen bond, stacking, and hydrophobic interaction makes them effective against almost all cancer types. In the present paper the author discusses the way which is connected with chemical structure of monocyclic azoles and their anticancer activity namely the ability of these compounds to intercalate with DNA, to inhibit some enzymes and to interfere cellular signaling pathways. Interestingly, several azole derivatives have been seen to be effective in preclinical efficacy studies as well as in clinical trials and are considered to be potent in overcoming the problem of resistance and side effects of the common anticancer agents. As the synthetic chemistry progresses, the structural system of the azoles has diversified and development in the pharmacology has become more specific. This has helped in enhancing the formation of new molecules in the azole class with improved selectivity and efficacy. Furthermore, the comprehensive review explains how computational chemistry and structure‐activity relationship (SAR) approaches are applied to the design of future‐generation azole compounds. In light of these facts, this article is designed to give a broad overview of the current state of monocyclic azole‐based anticancer agents in an attempt to further assert its therapeutic promise and spur further attempts at infusing the said agents into the cancer therapeutics fray. The discoveries made in this study may allow the development the radical different therapeutic approaches, which could lead to improved and targeted treatment of cancer.

Oxazole-based compounds as anticancer agents.

Oxazole: A Promising Building Block for the Development of Potent Antitumor Agents.

Synthetic Strategies to Glycosylated Nitrogen-Containing Heterocyclic Compounds with Potential Anticancer Activities

New Oxazolo[5,4- d]pyrimidines as Potential Anticancer Agents: Their Design, Synthesis, and In Vitro Biological Activity Research

Synthesis and in vitro anticancer evaluation of functionalized 5-(4-piperazin-1-yl)-2-aryloxazoles and 5-[(4-arylsulfonyl)piperazin-1-yl]-2-phenyloxazoles

Review on Therapeutic Diversity of Oxazole Scaffold: An Update

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds

Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents

The Benzoxazole Heterocycle: A Comprehensive Review of the Most Recent Medicinal Chemistry Developments of Antiproliferative, Brain-Penetrant, and Anti-inflammatory Agents

An insight into recent developments in imidazole based heterocyclic compounds as anticancer agents: Synthesis, SARs, and mechanism of actions

1,3,4-Oxadiazole Derivatives As Potential Biological Agents

Azole Derivatives: Cutting‐Edge Agents in Cancer Therapy

Pyrazole Derivatives As Antitumor, Anti-Inflammatory and Antibacterial Agents

Synthesis, Characterization, and in Vitro Anticancer Evaluation of 2-Aryl-4-Arylsulfonyl-5-RS-1,3-Oxazoles

Thiazole moiety: A promising scaffold for anticancer drug discovery

Isoxazole compounds: Unveiling the synthetic strategy, in-silico SAR & toxicity studies and future perspective as PARP inhibitor in cancer therapy

Recent advances on quinoxalines as target‐oriented chemotherapeutic anticancer agents through apoptosis

Pyrazole Paradigms: Unveiling Synthetic Pathways and Unraveling Anti-Cancer Potential

A comprehensive review on biological activities of oxazole derivatives

Review on Chemistry of Oxazole derivatives: Current to Future Therapeutic Prospective